Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2007
The objective of this study is to evaluate the safety and effectiveness of the experimental drug AST-120 in treating patients with non-constipating IBS. The study will test whether or not patients receiving AST-120 experience at least a 50% reduction in the number of days with abdominal pain compared to placebo.
Epistemonikos ID: 02de05a4c1936e49a10e2aaa5281d154be9c4ab2
First added on: Jan 28, 2022